PROCTOFOAM HC Drug Patent Profile
✉ Email this page to a colleague
When do Proctofoam Hc patents expire, and when can generic versions of Proctofoam Hc launch?
Proctofoam Hc is a drug marketed by Mylan Speciality Lp and is included in one NDA.
The generic ingredient in PROCTOFOAM HC is hydrocortisone acetate; pramoxine hydrochloride. There are sixty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the hydrocortisone acetate; pramoxine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROCTOFOAM HC?
- What are the global sales for PROCTOFOAM HC?
- What is Average Wholesale Price for PROCTOFOAM HC?
Summary for PROCTOFOAM HC
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 7 |
Clinical Trials: | 1 |
Patent Applications: | 8 |
DailyMed Link: | PROCTOFOAM HC at DailyMed |
Recent Clinical Trials for PROCTOFOAM HC
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The Hospital for Sick Children | |
Duchesnay Inc. |
Pharmacology for PROCTOFOAM HC
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for PROCTOFOAM HC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Speciality Lp | PROCTOFOAM HC | hydrocortisone acetate; pramoxine hydrochloride | AEROSOL, METERED;TOPICAL | 086195-001 | Approved Prior to Jan 1, 1982 | BX | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |